Stock AGN ALGERNON PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Algernon Pharmaceuticals Inc.

Equities

AGN

CA01559R4008

Market Closed - Canadian Securities Exchange
Other stock markets
 17:31:50 25/06/2024 BST 		5-day change 1st Jan Change
0.12 CAD 0.00% Intraday chart for Algernon Pharmaceuticals Inc. -4.00% +84.62%
04-30 Algernon Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024 CI
04-10 Algernon Pharmaceuticals Inc. announced that it has received CAD 0.017 million in funding CI

Analyst Reco.

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Algernon Pharmaceuticals : Announces Research Analyst Coverage by Mackie Research with an $0.80/share Target PriceAugust 24, 2020
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AGN Stock
  4. News Algernon Pharmaceuticals Inc.
  5. Analyst Reco.